Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Clasificación en acciones #5445
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Precio por acción
$90.29
Última sincronización: 2026-08-26
Capitalización bursátil
$2.69B
Cambio (1 día)
3.30%
Cambio (1 año)
-30.11%
País
US
Comercio GeneDx Holdings Corp. (WGS)

Categoría

Ratio P/S de GeneDx Holdings Corp. (WGS)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de GeneDx Holdings Corp., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de GeneDx Holdings Corp. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras